These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7333326)

  • 21. Noninvasive assessment in vivo of hepatic drug metabolism in health and disease.
    Vesell ES
    Ann N Y Acad Sci; 1984; 428():293-307. PubMed ID: 6378027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipyrine clearance during occupational exposure to styrene.
    Døssing M
    Br J Ind Med; 1983 May; 40(2):224-8. PubMed ID: 6131688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients.
    Mahmoud M; Abdel-Kader R; Hassanein M; Saleh S; Botros S
    Eur J Pharmacol; 2007 Aug; 569(3):222-7. PubMed ID: 17628532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simplified determination of antipyrine clearance by liquid chromatography of a microsample of saliva or plasma.
    el-Yazigi A; Raines DA; Ali H; Sieck J; Ernst P; Dossing M
    Pharm Res; 1991 Feb; 8(2):269-72. PubMed ID: 2023880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticonvulsant therapy and cortisol elimination.
    Evans PJ; Walker RF; Peters JR; Dyas J; Riad-Fahmy D; Thomas JP; Rimmer E; Tsanaclis L; Scanlon MF
    Br J Clin Pharmacol; 1985 Aug; 20(2):129-32. PubMed ID: 4041330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of isoniazid on antipyrine clearance in man.
    Grech-Belanger O; Belanger PM; Lachance J
    J Clin Pharmacol; 1983; 23(11-12):540-4. PubMed ID: 6662978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis.
    el-Raghy I; Back DJ; Osman F; Nafeh MA; Orme ML
    Br J Clin Pharmacol; 1985 Oct; 20(4):313-6. PubMed ID: 4074599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a non-steroid anti-inflammatory agent on the drug metabolizing activity of the human liver.
    Gachályi B; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):353-4. PubMed ID: 6469424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of antipyrine in epileptic patients.
    Rimmer EM; Routledge PA; Tsanaclis LM; Richens A
    Br J Clin Pharmacol; 1986 May; 21(5):511-4. PubMed ID: 3718808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal antipyrine metabolism in patients with cholesterol cholelithiasis. Evidence that the disease is not due to generalized hepatic microsomal dysfunction.
    Hepner GW; Vesell ES
    Am J Dig Dis; 1975 Jan; 20(1):9-12. PubMed ID: 1115054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between antipyrine and aminopyrine.
    Vesell ES; Passananti GT; Hepner GW
    Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of the antipyrine test in assessing liver function in patients with insulin-dependent diabetes mellitus].
    Khanina EV; Gorshteĭn ES; Michurina SP
    Probl Endokrinol (Mosk); 1990; 36(3):14-5. PubMed ID: 2395825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered elimination of antipyrine in patients with acute viral hepatitis.
    Burnett DA; Barak AJ; Tuma DJ; Sorrell MF
    Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clearance of antipyrine-dependence of quantitative liver function.
    Andreasen PB; Ranek L; Statland BE; Tygstrup N
    Eur J Clin Invest; 1974 Apr; 4(2):129-34. PubMed ID: 4832718
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of the functional status of hepatic microsomal enzymes in workers exposed to carbon dioxide and vinyl chloride by using the antipyrine test].
    Lutz W; Stankiewicz A; Krajewska B
    Med Pr; 1987; 38(3):157-66. PubMed ID: 3118136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
    Loft S; Nielsen AJ; Borg BE; Poulsen HE
    Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of antipyrine clearance to measure liver damage in psoriatic patients receiving methotrexate.
    Paramsothy J; Strange R; Sharif H; Collins M; Shaw P; Lawrence CM
    Br J Dermatol; 1988 Dec; 119(6):761-5. PubMed ID: 3203069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH; Back DJ; Breckenridge AM; Howells RE
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.